Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Report

Plasma Protein Binding and PK/PD of Total and Unbound Temocillin Non-ICU Patients (TEMODELTA)

  • Authors : Paul M. Tulkens, Professor

  • Source: Plasma Protein Binding and Population Pharmacokinetics and Pharmacodynamics of Total and Unbound Temocillin in Patients With Complicated

تفاصيل العنوان

×
Report

Phase 0 Study in Healthy, Hepatic and Renal Impaired Subjects to Obtain Plasma for Lenvatinib Protein Binding

  • Source: A Multicenter Phase 0 Study In Healthy Subjects and Subjects With Either Hepatic Or Renal Impairment To Obtain Plasma For Assessment In Vitro Lenvatinib Protein

تفاصيل العنوان

×
Report

Plasma Protein Binding Characteristics of Voriconazole

  • Source: Impact of Hypoalbuminemia on Voriconazole Pharmacokinetics in Critically Ill Adult Patients.

تفاصيل العنوان

×
Report

Exploring Vancomycin Disposition in Neonates

  • Source: Exploring Vancomycin Disposition in Neonates: Paired Analysis of Vancomycin Concentrations Using Immunoassay and Liquid-chromatography-tandem Mass Spectrometry. Determination of Vancomycin

تفاصيل العنوان

×
Report

Potential for Cortisol Suppression With the Use of High Volume Nasal Mometasone Irrigations in Varying Dosages.

  • Source: Potential for Cortisol Suppression With the Use of High Volume Nasal Mometasone Irrigations in Varying Dosages.Smith KA, French G, Mechor B, Rudmik L. Safety of long-term high-volume sinonasal

تفاصيل العنوان

×
Report

Topical Bupivacaine Effect On The Response To Awake Extubation During Emergence From General Anesthesia

  • Authors : Shereen Elsayed Abd Ellatif, principal investigator, lecturer

  • Source: Topical Bupivacaine Effect On The Response To Awake Extubation During Emergence From General Anesthesia In Patients Undergoing Elective Thyroidectomy. A Randomized Controlled StudyShabnum T, Ali

تفاصيل العنوان

×
Report

ZF2001 Booster Immunization Clinical Trials of 6 Months After the Completion of Basic Immunization

  • Source: To Evaluate the Immunogenicity and Safety of Booster Immunization 6 Months After the Completion of Basic Immunization of Recombinant Novel Coronavirus Vaccine (CHO Cell) in People 18 Years Old and

تفاصيل العنوان

×
Report

Recombinant New Coronavirus Vaccine (CHO Cells) to Prevent SARS-CoV-2(COVID-19) Phase I Clinical Trial (3~17 Years Old)

  • Source: A Randomized, Blinded, Placebo-controlled Phase Ⅰ Clinical Trial of Recombinant New Coronavirus Vaccine (CHO Cells) in the Safety and Tolerability of Healthy People Aged 3 to 17 Years of Age

تفاصيل العنوان

×
  • 1-10 ل  122 نتائج ل ""Protein Binding""